| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024605 |
| Receipt No. | R000028312 |
| Official scientific title of the study | Trial of the effect of food ingredients on mobility and muscle strength |
| Date of disclosure of the study information | 2018/06/30 |
| Last modified on | 2017/11/01 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Trial of the effect of food ingredients on mobility and muscle strength | |
| Title of the study (Brief title) | Trial of the effect of food ingredients on mobility and muscle strength | |
| Region |
|
|
| Condition | |||
| Condition | Not applicable | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effect of food ingredients on mobility and muscle strength |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The stage of the locomotive syndrome risk based on three indices for assessing risk of locomotive syndrome at 8th week, 12th week and 16th week of intake |
| Key secondary outcomes | Measured value of three indices for assessing risk of locomotive syndrome at 8th week, 12th week and 16th week of intake |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | YES |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Supplement containing food ingredients such as glucosamine, 16 Weeks | |
| Interventions/Control_2 | Supplement not containing food ingredients such as glucosamine, 16 weeks | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Women and men aged 40 to 74 years at the time of acquisition of agreement in participating in this study
2) Presence of knee pain 3) Person who begins declining in mobility 4) Person who can come to the medical organization for the measurement at the date of visiting 5) Person who can understand the purpose and content of this study and agree in writing to participate in this study |
|||
| Key exclusion criteria | 1) Kellgren-Lawrence grades II-IV
2) Presence of hyperuricemia 3) Presence of rheumatoid arthritis that may cause joint pain 4) Surgical treatment of knee joint(s) needed or undergone 5) Need for pharmacological articular treatments during the study period 6) Presence of disease in locomotor organs affecting the efficacy assessment of this study 7) Presence of history of osseous or articular diseases other than OA within the past 3 months 8) Use of product affecting the data of this study, such as medicine, food for specified health use, supplement, diet food 9) Daily use of a cane or a supporter 10) Daily use of hot spa or massage therapy 11) Daily or occasional vigorous exercise 12) Female in pregnancy, lactation and scheduled pregnancy period 13) With previous and present serious disease such as liver disorder, kidney disorder, cardiac affection, lung disorder, digestive disorder, organ disorder, diabetes mellitus, food allergy 14) Investigator's judgment for other reason |
|||
| Target sample size | 110 | |||
| Research contact person | |
| Name of lead principal investigator | Takayuki Izumo |
| Organization | Suntory Wellness Limited |
| Division name | Institute for Health Care Science |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan |
| TEL | 050-3182-0630 |
| Takayuki_Izumo@suntory.co.jp | |
| Public contact | |
| Name of contact person | Noriyuki Kanzaki |
| Organization | Suntory Wellness Limited |
| Division name | Institute for Health Care Science |
| Address | 8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, 619-0284, Japan |
| TEL | 050-3182-0666 |
| Homepage URL | |
| Noriyuki_Kanzaki@suntory.co.jp | |
| Sponsor | |
| Institute | Suntory Wellness Limited |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028312 |